Overlap matrix completion for predicting drug-associated indications
Fig 2
The workflow of constructing the DrNet-Pro-Dis network and the DisNet-Pro-Dr network.
(a) DrNet-Dis network and its similarity matrix. (b) Drug–protein interactions and corresponding adjacency matrix. (c) Disease–protein associations and corresponding adjacency matrix. (d) DisNet-Dr network and its block adjacency matrix. (e) DrNet-Pro-Dis network and its block adjacency matrix. (f) DisNet-Pro-Dr network and its block adjacency matrix.